Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers, Small cell lung cancer
Open
Phase 1/2
This trial is looking at pumitamig in combination with BNT324 for lung cancer. It is for people whose cancer has spread, come back after treatment or got worse during treatment.
Cancer that has spread is called advanced cancer. Cancer that has come back after treatment is called relapsed cancer. Cancer that gets worse during treatment is called refractory cancer.
People can join the trial if they have:
non small cell lung cancer or
small cell lung cancer
Recruitment start: 28 July 2025
Recruitment end: 31 March 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Martin Forster
BioNTech SE
IQVIA
Last reviewed: 03 Jul 2026
CRUK internal database number: 20150
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
